Trial to Evaluate Nonavalent HPV Vaccine as a Secondary Prevention in Patients Treated for Human Papilloma Virus Related High-grade Squamous Intraepithelial Lesions

Clinical trial NCT07431502 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07431502
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Patients With Primary HPV High-grade Squamous Intra-epithelial Lesions (HSIL) at Vulvar Site Patients With Primary HPV High-grade Squamous Intra-epithelial Lesions (HSIL) at Vaginal Site Patients With Primary HPV High-grade Squamous Intra-epithelial Lesions (HSIL) at Penile Site Patients With Primary HPV High-grade Squamous Intra-epithelial Lesions (HSIL) at Cervical Site Patients With Primary HPV High-grade Squamous Intra-epithelial Lesions (HSIL) at Anal Site

Start date: 2026-05-01
Primary completion: 2030-11-01
Enrollment: 984

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.